Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Pain 5Colorectal Neoplasms 5Neoplasms 4Breast Neoplasms 4Stomatitis 3Neoplasm Metastasis 3Adenoma 3Urologic Neoplasms 2Stomach Neoplasms 2Mucositis 2Insulin Resistance 2Head and Neck Neoplasms 2Vulvodynia 1Urologic Diseases 1Urolithiasis 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pain, Postoperative 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mobility Limitation 1Melanoma 1MRSA Colonization 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Mitomycin 4Carboplatin 4Sunitinib 3Pemetrexed 3dodecyl maltoside 2cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urologic Neoplasms × Water × Clear all
NCT05913245 2023-06-22

Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Phase NA Unknown
66 enrolled
Genitourinary

Fasting, Urologic Neoplasms

NCT01803295 2017-06-16

OPTIMA

UroGen Pharma Ltd.

Phase NA Completed
80 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡